BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 5974899)

  • 1. [Maple syrup urine disease. (Valine-leucine-uria)].
    Platt D; Beneke G; Peiffer J; Schmidt GW
    Med Welt; 1966 May; 19():1089-93. PubMed ID: 5974899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H; Bickel H; Feist D; Lutz P
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC; Martel SB; Goluboff N
    Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
    [No Abstract]   [Full Text] [Related]  

  • 4. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 5. An 11-day-old boy with lethargy, poor feeding, vomiting. Maple syrup urine disease.
    Charrow J
    Pediatr Ann; 2005 Oct; 34(10):772-4. PubMed ID: 16285630
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
    Sander C; Clotten R; Noetzel H; Wehinger H
    Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M aple syrup urine disease. A review with a report of an additional case.
    Schwartz JF; Kolendrianos ET
    Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Maple syrup urine disease].
    Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
    Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neonatal leucinosis with favourable course. Therapeutic problems].
    Astruc J; Froye E; Luciani JM; Bellet H; Magnan de Bornier P; Brunel D
    Ann Pediatr (Paris); 1977 Sep; 24(8-9):605-10. PubMed ID: 16211914
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy].
    Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U
    Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613
    [No Abstract]   [Full Text] [Related]  

  • 12. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
    Allen RJ; Frey HJ; Fleming LM; Owings CL
    Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
    [No Abstract]   [Full Text] [Related]  

  • 13. Maple syrup urine disease: coenzyme function and prenatal monitoring.
    Elsas LJ; Priest JH; Wheeler FB; Danner DJ; Pask BA
    Metabolism; 1974 Jun; 23(6):569-79. PubMed ID: 4857216
    [No Abstract]   [Full Text] [Related]  

  • 14. Maple syrup urine disease. Four years' experience with dietary treatment of a case.
    Dickinson JP; Holton JB; Lewis GM; Littlewood JM; Steel AE
    Acta Paediatr Scand; 1969 Jul; 58(4):341-51. PubMed ID: 5824823
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 16. Maple syrup urine disease. Two cases in Israel.
    Chemke J; Levin S
    Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
    Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
    Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
    [No Abstract]   [Full Text] [Related]  

  • 19. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
    WESTALL RG
    Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
    [No Abstract]   [Full Text] [Related]  

  • 20. [Attempted diet therapy of a case of maple syrup disease].
    Mainardi PC; Antener I
    Pediatria (Napoli); 1970 Jul; 78(3):540-60. PubMed ID: 5474982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.